This component describes research translation and information dissemination activities that are designed to provide greater service to the research community, clinical practitioners, policymakers, and health service administrators at the state and national levels. Working in collaboration with international programs like the Worid Health Organization (WHO) the Pan American Health Organization (PAHO), and the EU/USA Transatlantic Dialogue on Underage Drinking, we propose to conduct the following activities over a five-year period: 1) Dissemination of alcohol screening, brief inten/ention and referral to treatment (SBIRT) technologies at the state and national levels. These activities will be conducted in collaboration with the WHO, PAHO and the federal Center for Substance Abuse Treatment, and will include the dissemination of a new SBIRT training package in English and Spanish. 2) Dissemination of evidence-based alcohol policies to address underage drinking. This subcomponent will use the resources developed by an international consortium of alcohol experts (the EU-USA Transatlantic Dialogue) to develop a Users Manual and training workshop for alcohol researchers and other professionals interested in translating research into practice at the state and national levels. 3) Dissemination of guidelines on the ethical challenges associated with research and research translation related to the genetics of alcoholism. The guidelines were recently developed by the UCONN ARC and will now be disseminated to the alcohol research community in both workshop and on-line formats designed to improve ethical awareness of alcohol researchers.
The public heahh relevance of this component lies in its ability to disseminate evidence-based practices to constituency groups interested in alcohol research, treatment and policy. The SBIRT training workshops represent a classic public health approach to early intervention that will advance the health of primary care patients. The alcohol policy and genomic ethics workshops will disseminate evidence-based research and practices to alcohol scientists, thereby advancing the public health impact of alcohol research.
|Petry, Nancy M; Alessi, Sheila M; Byrne, Shannon et al. (2015) Reinforcing adherence to antihypertensive medications. J Clin Hypertens (Greenwich) 17:33-8|
|O'Hara, Ross E; Armeli, Stephen; Tennen, Howard (2015) College students' drinking motives and social-contextual factors: Comparing associations across levels of analysis. Psychol Addict Behav 29:420-9|
|Petry, Nancy M; Alessi, Sheila M; Barry, Danielle et al. (2015) Standard magnitude prize reinforcers can be as efficacious as larger magnitude reinforcers in cocaine-dependent methadone patients. J Consult Clin Psychol 83:464-72|
|O'Hara, Ross E; Armeli, Stephen; Tennen, Howard (2014) College students' daily-level reasons for not drinking. Drug Alcohol Rev 33:412-9|
|O'Hara, Ross E; Armeli, Stephen; Tennen, Howard (2014) Drinking-to-cope motivation and negative mood-drinking contingencies in a daily diary study of college students. J Stud Alcohol Drugs 75:606-14|
|Andrade, Leonardo F; Barry, Danielle; Litt, Mark D et al. (2014) Maintaining high activity levels in sedentary adults with a reinforcement-thinning schedule. J Appl Behav Anal 47:523-36|
|Arias, Albert J; Covault, Jonathan; Feinn, Richard et al. (2014) A GABRA2 variant is associated with increased stimulation and 'high' following alcohol administration. Alcohol Alcohol 49:1-9|
|Weiss, Lindsay M; Petry, Nancy M (2014) Substance abuse treatment patients with early onset cocaine use respond as well to contingency management interventions as those with later onset cocaine use. J Subst Abuse Treat 47:146-50|
|Milivojevic, Verica; Feinn, Richard; Kranzler, Henry R et al. (2014) Variation in AKR1C3, which encodes the neuroactive steroid synthetic enzyme 3?-HSD type 2 (17?-HSD type 5), moderates the subjective effects of alcohol. Psychopharmacology (Berl) 231:3597-608|
|Kranzler, Henry R; Armeli, Stephen; Feinn, Richard et al. (2014) GRIK1 genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink. Int J Neuropsychopharmacol 17:1549-56|
Showing the most recent 10 out of 87 publications